|
Abramovich, C., Yakobson, B., Chebath, J. and Revel, M. (1997) A protein-arginine methyltransferase binds to the intracytoplasmic domain of the IFNAR1 chain in the type I interferon receptor. Embo J, 16, 260-266.
Ajima, R., Ikematsu, N., Ohsugi, M., Yoshida, Y. and Yamamoto, T. (2000) Cloning and characterization of the mouse tob2 gene. Gene, 253, 215-220.
Aletta, J.M., Cimato, T.R. and Ettinger, M.J. (1998) Protein methylation: a signal event in post-translational modification. Trends Biochem Sci, 23, 89-91.
Andela, V.B., Gordon, A.H., Zotalis, G., Rosier, R.N., Goater, J.J., Lewis, G.D., Schwarz, E.M., Puzas, J.E. and O'Keefe, R.J. (2003) NFkappaB: a pivotal transcription factor in prostate cancer metastasis to bone. Clin Orthop Relat Res, S75-85.
Aoki, J., Umeda, M., Takio, K., Titani, K., Utsumi, H., Sasaki, M. and Inoue, K. (1991) Neural cell adhesion molecule mediates contact-dependent inhibition of growth of near-diploid mouse fibroblast cell line m5S/1M. J Cell Biol, 115, 1751-1761.
Bogdan, J.A., Adams-Burton, C., Pedicord, D.L., Sukovich, D.A., Benfield, P.A., Corjay, M.H., Stoltenborg, J.K. and Dicker, I.B. (1998) Human carbon catabolite repressor protein (CCR4)-associative factor 1: cloning, expression and characterization of its interaction with the B-cell translocation protein BTG1. Biochem J, 336 (Pt 2), 471-481.
Brach, M.A., Hass, R., Sherman, M.L., Gunji, H., Weichselbaum, R. and Kufe, D. (1991) Ionizing radiation induces expression and binding activity of the nuclear factor kappa B. J Clin Invest, 88, 691-695.
Bradbury, A., Possenti, R., Shooter, E.M. and Tirone, F. (1991) Molecular cloning of PC3, a putatively secreted protein whose mRNA is induced by nerve growth factor and depolarization. Proc Natl Acad Sci U S A, 88, 3353-3357.
Buanne, P., Corrente, G., Micheli, L., Palena, A., Lavia, P., Spadafora, C., Lakshmana, M.K., Rinaldi, A., Banfi, S., Quarto, M., Bulfone, A. and Tirone, F. (2000) Cloning of PC3B, a novel member of the PC3/BTG/TOB family of growth inhibitory genes, highly expressed in the olfactory epithelium. Genomics, 68, 253-263.
Califice, S., Waltregny, D., Castronovo, V. and van den Brule, F. (2004) [Prostate carcinoma cell lines and apoptosis: a review]. Rev Med Liege, 59, 704-710.
Chen, C.Y., Jang, J.H., Li, M.H. and Surh, Y.J. (2005) Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells. Biochem Biophys Res Commun, 331, 993-1000.
Christman, J.W., Lancaster, L.H. and Blackwell, T.S. (1998) Nuclear factor kappa B: a pivotal role in the systemic inflammatory response syndrome and new target for therapy. Intensive Care Med, 24, 1131-1138.
Clagett-Dame, M. and DeLuca, H.F. (2002) The role of vitamin A in mammalian reproduction and embryonic development. Annu Rev Nutr, 22, 347-381.
Corjay, M.H., Kearney, M.A., Munzer, D.A., Diamond, S.M. and Stoltenborg, J.K. (1998) Antiproliferative gene BTG1 is highly expressed in apoptotic cells in macrophage-rich areas of advanced lesions in Watanabe heritable hyperlipidemic rabbit and human. Lab Invest, 78, 847-858.
Cortes, U., Moyret-Lalle, C., Falette, N., Duriez, C., Ghissassi, F.E., Barnas, C., Morel, A.P., Hainaut, P., Magaud, J.P. and Puisieux, A. (2000) BTG gene expression in the p53-dependent and -independent cellular response to DNA damage. Mol Carcinog, 27, 57-64.
Dasika, G.K., Lin, S.C., Zhao, S., Sung, P., Tomkinson, A. and Lee, E.Y. (1999) DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis. Oncogene, 18, 7883-7899.
Della Ragione, F., Cucciolla, V., Criniti, V., Indaco, S., Borriello, A. and Zappia, V. (2002) Antioxidants induce different phenotypes by a distinct modulation of signal transduction. FEBS Lett, 532, 289-294.
Donato, L.J. and Noy, N. (2005) Suppression of mammary carcinoma growth by retinoic acid: proapoptotic genes are targets for retinoic acid receptor and cellular retinoic acid-binding protein II signaling. Cancer Res, 65, 8193-8199.
Dragnev, K.H., Rigas, J.R. and Dmitrovsky, E. (2000) The retinoids and cancer prevention mechanisms. Oncologist, 5, 361-368.
Duriez, C., Falette, N., Audoynaud, C., Moyret-Lalle, C., Bensaad, K., Courtois, S., Wang, Q., Soussi, T. and Puisieux, A. (2002) The human BTG2/TIS21/PC3 gene: genomic structure, transcriptional regulation and evaluation as a candidate tumor suppressor gene. Gene, 282, 207-214.
Fan, R., Kumaravel, T.S., Jalali, F., Marrano, P., Squire, J.A. and Bristow, R.G. (2004) Defective DNA strand break repair after DNA damage in prostate cancer cells: implications for genetic instability and prostate cancer progression. Cancer Res, 64, 8526-8533.
Ficazzola, M.A., Fraiman, M., Gitlin, J., Woo, K., Melamed, J., Rubin, M.A. and Walden, P.D. (2001) Antiproliferative B cell translocation gene 2 protein is down-regulated post-transcriptionally as an early event in prostate carcinogenesis. Carcinogenesis, 22, 1271-1279.
Fidler, C., Wainscoat, J.S. and Boultwood, J. (1999) The human POP2 gene: identification, sequencing, and mapping to the critical region of the 5q- syndrome. Genomics, 56, 134-136.
Fletcher, B.S., Lim, R.W., Varnum, B.C., Kujubu, D.A., Koski, R.A. and Herschman, H.R. (1991) Structure and expression of TIS21, a primary response gene induced by growth factors and tumor promoters. J Biol Chem, 266, 14511-14518.
Fridman, J.S. and Lowe, S.W. (2003) Control of apoptosis by p53. Oncogene, 22, 9030-9040.
Gao, S., Liu, G.Z. and Wang, Z. (2004) Modulation of androgen receptor-dependent transcription by resveratrol and genistein in prostate cancer cells. Prostate, 59, 214-225.
Gerondakis, S., Grossmann, M., Nakamura, Y., Pohl, T. and Grumont, R. (1999) Genetic approaches in mice to understand Rel/NF-kappaB and IkappaB function: transgenics and knockouts. Oncogene, 18, 6888-6895.
Giguere, V. (1999) Orphan nuclear receptors: from gene to function. Endocr Rev, 20, 689-725.
Guardavaccaro, D., Corrente, G., Covone, F., Micheli, L., D'Agnano, I., Starace, G., Caruso, M. and Tirone, F. (2000) Arrest of G(1)-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription. Mol Cell Biol, 20, 1797-1815.
Guehenneux, F., Duret, L., Callanan, M.B., Bouhas, R., Hayette, S., Berthet, C., Samarut, C., Rimokh, R., Birot, A.M., Wang, Q., Magaud, J.P. and Rouault, J.P. (1997) Cloning of the mouse BTG3 gene and definition of a new gene family (the BTG family) involved in the negative control of the cell cycle. Leukemia, 11, 370-375.
Hayashi, K., Yokozaki, H., Naka, K., Yasui, W., Lotan, R. and Tahara, E. (2001) Overexpression of retinoic acid receptor beta induces growth arrest and apoptosis in oral cancer cell lines. Jpn J Cancer Res, 92, 42-50.
Hayden, M.S. and Ghosh, S. (2004) Signaling to NF-kappaB. Genes Dev, 18, 2195-2224.
Hazan, U., Thomas, D., Alcami, J., Bachelerie, F., Israel, N., Yssel, H., Virelizier, J.L. and Arenzana-Seisdedos, F. (1990) Stimulation of a human T-cell clone with anti-CD3 or tumor necrosis factor induces NF-kappa B translocation but not human immunodeficiency virus 1 enhancer-dependent transcription. Proc Natl Acad Sci U S A, 87, 7861-7865.
Hazzalin, C.A. and Mahadevan, L.C. (2002) MAPK-regulated transcription: a continuously variable gene switch? Nat Rev Mol Cell Biol, 3, 30-40.
Holland, N.D., Zhang, S.C., Clark, M., Panopoulou, G., Lehrach, H. and Holland, L.Z. (1997) Sequence and developmental expression of AmphiTob, an amphioxus homolog of vertebrate Tob in the PC3/BTG1/Tob family of tumor suppressor genes. Dev Dyn, 210, 11-18.
Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C.C. (1991) p53 mutations in human cancers. Science, 253, 49-53.
Hong, J.W., Ryu, M.S. and Lim, I.K. (2005) Phosphorylation of serine 147 of tis21/BTG2/pc3 by p-Erk1/2 induces Pin-1 binding in cytoplasm and cell death. J Biol Chem, 280, 21256-21263.
Hsieh, T.C., Wang, Z., Hamby, C.V. and Wu, J.M. (2005) Inhibition of melanoma cell proliferation by resveratrol is correlated with upregulation of quinone reductase 2 and p53. Biochem Biophys Res Commun, 334, 223-230.
Ikematsu, N., Yoshida, Y., Kawamura-Tsuzuku, J., Ohsugi, M., Onda, M., Hirai, M., Fujimoto, J. and Yamamoto, T. (1999) Tob2, a novel anti-proliferative Tob/BTG1 family member, associates with a component of the CCR4 transcriptional regulatory complex capable of binding cyclin-dependent kinases. Oncogene, 18, 7432-7441.
Jang, M., Cai, L., Udeani, G.O., Slowing, K.V., Thomas, C.F., Beecher, C.W., Fong, H.H., Farnsworth, N.R., Kinghorn, A.D., Mehta, R.G., Moon, R.C. and Pezzuto, J.M. (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science, 275, 218-220.
Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R.C., Ghafoor, A., Feuer, E.J. and Thun, M.J. (2005) Cancer statistics, 2005. CA Cancer J Clin, 55, 10-30.
Jin Cho, S., La, M., Ahn, J.K., Meadows, G.G. and Joe, C.O. (2001) Tob-mediated cross-talk between MARCKS phosphorylation and ErbB-2 activation. Biochem Biophys Res Commun, 283, 273-277.
Jin, F., Liu, X., Zhou, Z., Yue, P., Lotan, R., Khuri, F.R., Chung, L.W. and Sun, S.Y. (2005) Activation of nuclear factor-kappaB contributes to induction of death receptors and apoptosis by the synthetic retinoid CD437 in DU145 human prostate cancer cells. Cancer Res, 65, 6354-6363.
Kaighn, M.E., Narayan, K.S., Ohnuki, Y., Lechner, J.F. and Jones, L.W. (1979) Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol, 17, 16-23.
Kawakubo, H., Carey, J.L., Brachtel, E., Gupta, V., Green, J.E., Walden, P.D. and Maheswaran, S. (2004) Expression of the NF-kappaB-responsive gene BTG2 is aberrantly regulated in breast cancer. Oncogene, 23, 8310-8319.
Kawate, H., Wu, Y., Ohnaka, K., Nawata, H. and Takayanagi, R. (2005) Tob proteins suppress steroid hormone receptor-mediated transcriptional activation. Mol Cell Endocrinol, 230, 77-86.
Koh, S.S., Chen, D., Lee, Y.H. and Stallcup, M.R. (2001) Synergistic enhancement of nuclear receptor function by p160 coactivators and two coactivators with protein methyltransferase activities. J Biol Chem, 276, 1089-1098.
Kwon, Y.K., Jun, J.M., Shin, S.W., Cho, J.W. and Suh, S.I. (2005) Curcumin decreases cell proliferation rates through BTG2-mediated cyclin D1 down-regulation in U937 cells. Int J Oncol, 26, 1597-1603.
Lee, H., Cha, S., Lee, M.S., Cho, G.J., Choi, W.S. and Suk, K. (2003) Role of antiproliferative B cell translocation gene-1 as an apoptotic sensitizer in activation-induced cell death of brain microglia. J Immunol, 171, 5802-5811.
Lee, J.T., Jr. and McCubrey, J.A. (2002) The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia. Leukemia, 16, 486-507.
Levine, A.J. (1997) p53, the cellular gatekeeper for growth and division. Cell, 88, 323-331.
Lim, I.K. (2006) TIS21 (/BTG2/PC3) as a link between ageing and cancer: cell cycle regulator and endogenous cell death molecule. J Cancer Res Clin Oncol, 132, 417-426.
Lim, I.K., Lee, M.S., Lee, S.H., Kim, N.K., Jou, I., Seo, J.S. and Park, S.C. (1995) Differential expression of TIS21 and TIS1 genes in the various organs of Balb/c mice, thymic carcinoma tissues and human cancer cell lines. J Cancer Res Clin Oncol, 121, 279-284.
Lim, I.K., Lee, M.S., Ryu, M.S., Park, T.J., Fujiki, H., Eguchi, H. and Paik, W.K. (1998) Induction of growth inhibition of 293 cells by downregulation of the cyclin E and cyclin-dependent kinase 4 proteins due to overexpression of TIS21. Mol Carcinog, 23, 25-35.
Lin, A. and Karin, M. (2003) NF-kappaB in cancer: a marked target. Semin Cancer Biol, 13, 107-114.
Lin, W.J., Gary, J.D., Yang, M.C., Clarke, S. and Herschman, H.R. (1996) The mammalian immediate-early TIS21 protein and the leukemia-associated BTG1 protein interact with a protein-arginine N-methyltransferase. J Biol Chem, 271, 15034-15044.
Lindholm, P.F., Bub, J., Kaul, S., Shidham, V.B. and Kajdacsy-Balla, A. (2000) The role of constitutive NF-kappaB activity in PC-3 human prostate cancer cell invasive behavior. Clin Exp Metastasis, 18, 471-479.
Liu, H.Y., Badarinarayana, V., Audino, D.C., Rappsilber, J., Mann, M. and Denis, C.L. (1998) The NOT proteins are part of the CCR4 transcriptional complex and affect gene expression both positively and negatively. Embo J, 17, 1096-1106.
Liu, H.Y., Toyn, J.H., Chiang, Y.C., Draper, M.P., Johnston, L.H. and Denis, C.L. (1997) DBF2, a cell cycle-regulated protein kinase, is physically and functionally associated with the CCR4 transcriptional regulatory complex. Embo J, 16, 5289-5298.
MacLachlan, T.K. and El-Deiry, W.S. (2002) Apoptotic threshold is lowered by p53 transactivation of caspase-6. Proc Natl Acad Sci U S A, 99, 9492-9497.
MacLachlan, T.K., Takimoto, R. and El-Deiry, W.S. (2002) BRCA1 directs a selective p53-dependent transcriptional response towards growth arrest and DNA repair targets. Mol Cell Biol, 22, 4280-4292.
Matsuda, S., Kawamura-Tsuzuku, J., Ohsugi, M., Yoshida, M., Emi, M., Nakamura, Y., Onda, M., Yoshida, Y., Nishiyama, A. and Yamamoto, T. (1996) Tob, a novel protein that interacts with p185erbB2, is associated with anti-proliferative activity. Oncogene, 12, 705-713.
Matsuda, S., Rouault, J., Magaud, J. and Berthet, C. (2001) In search of a function for the TIS21/PC3/BTG1/TOB family. FEBS Lett, 497, 67-72.
McCurrach, M.E., Connor, T.M., Knudson, C.M., Korsmeyer, S.J. and Lowe, S.W. (1997) bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. Proc Natl Acad Sci U S A, 94, 2345-2349.
Mgbonyebi, O.P., Russo, J. and Russo, I.H. (1998) Antiproliferative effect of synthetic resveratrol on human breast epithelial cells. Int J Oncol, 12, 865-869.
Mitchell, S.H., Zhu, W. and Young, C.Y. (1999) Resveratrol inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells. Cancer Res, 59, 5892-5895.
Miyamoto, S. and Verma, I.M. (1995) Rel/NF-kappa B/I kappa B story. Adv Cancer Res, 66, 255-292.
Montagnoli, A., Guardavaccaro, D., Starace, G. and Tirone, F. (1996) Overexpression of the nerve growth factor-inducible PC3 immediate early gene is associated with growth inhibition. Cell Growth Differ, 7, 1327-1336.
Morel, A.P., Sentis, S., Bianchin, C., Le Romancer, M., Jonard, L., Rostan, M.C., Rimokh, R. and Corbo, L. (2003) BTG2 antiproliferative protein interacts with the human CCR4 complex existing in vivo in three cell-cycle-regulated forms. J Cell Sci, 116, 2929-2936.
Narayanan, B.A., Narayanan, N.K., Re, G.G. and Nixon, D.W. (2003) Differential expression of genes induced by resveratrol in LNCaP cells: P53-mediated molecular targets. Int J Cancer, 104, 204-212.
Osborn, L., Kunkel, S. and Nabel, G.J. (1989) Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci U S A, 86, 2336-2340.
Palayoor, S.T., Youmell, M.Y., Calderwood, S.K., Coleman, C.N. and Price, B.D. (1999) Constitutive activation of IkappaB kinase alpha and NF-kappaB in prostate cancer cells is inhibited by ibuprofen. Oncogene, 18, 7389-7394.
Park, H.Y., Kim, M.K., Moon, S.I., Cho, Y.H. and Lee, C.H. (2006) Cell cycle arrest and apoptotic induction in LNCaP cells by MCS-C2, novel cyclin-dependent kinase inhibitor, through p53/p21WAF1/CIP1 pathway. Cancer Sci, 97, 430-436.
Pervaiz, S. (2003) Resveratrol: from grapevines to mammalian biology. Faseb J, 17, 1975-1985.
Pozo-Guisado, E., Merino, J.M., Mulero-Navarro, S., Lorenzo-Benayas, M.J., Centeno, F., Alvarez-Barrientos, A. and Fernandez-Salguero, P.M. (2005) Resveratrol-induced apoptosis in MCF-7 human breast cancer cells involves a caspase-independent mechanism with downregulation of Bcl-2 and NF-kappaB. Int J Cancer, 115, 74-84.
Prevot, D., Morel, A.P., Voeltzel, T., Rostan, M.C., Rimokh, R., Magaud, J.P. and Corbo, L. (2001) Relationships of the antiproliferative proteins BTG1 and BTG2 with CAF1, the human homolog of a component of the yeast CCR4 transcriptional complex: involvement in estrogen receptor alpha signaling pathway. J Biol Chem, 276, 9640-9648.
Prevot, D., Voeltzel, T., Birot, A.M., Morel, A.P., Rostan, M.C., Magaud, J.P. and Corbo, L. (2000) The leukemia-associated protein Btg1 and the p53-regulated protein Btg2 interact with the homeoprotein Hoxb9 and enhance its transcriptional activation. J Biol Chem, 275, 147-153.
Raburn, D.J., Hamil, K.G., Tsuruta, J.K., O'Brien, D.A. and Hall, S.H. (1995) Stage-specific expression of B cell translocation gene 1 in rat testis. Endocrinology, 136, 5769-5777.
Rimokh, R., Rouault, J.P., Wahbi, K., Gadoux, M., Lafage, M., Archimbaud, E., Charrin, C., Gentilhomme, O., Germain, D., Samarut, J. and et al. (1991) A chromosome 12 coding region is juxtaposed to the MYC protooncogene locus in a t(8;12)(q24;q22) translocation in a case of B-cell chronic lymphocytic leukemia. Genes Chromosomes Cancer, 3, 24-36.
Rodier, A., Marchal-Victorion, S., Rochard, P., Casas, F., Cassar-Malek, I., Rouault, J.P., Magaud, J.P., Mason, D.Y., Wrutniak, C. and Cabello, G. (1999) BTG1: a triiodothyronine target involved in the myogenic influence of the hormone. Exp Cell Res, 249, 337-348.
Rouault, J.P., Falette, N., Guehenneux, F., Guillot, C., Rimokh, R., Wang, Q., Berthet, C., Moyret-Lalle, C., Savatier, P., Pain, B., Shaw, P., Berger, R., Samarut, J., Magaud, J.P., Ozturk, M., Samarut, C. and Puisieux, A. (1996) Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway. Nat Genet, 14, 482-486.
Rouault, J.P., Prevot, D., Berthet, C., Birot, A.M., Billaud, M., Magaud, J.P. and Corbo, L. (1998) Interaction of BTG1 and p53-regulated BTG2 gene products with mCaf1, the murine homolog of a component of the yeast CCR4 transcriptional regulatory complex. J Biol Chem, 273, 22563-22569.
Rouault, J.P., Rimokh, R., Tessa, C., Paranhos, G., Ffrench, M., Duret, L., Garoccio, M., Germain, D., Samarut, J. and Magaud, J.P. (1992) BTG1, a member of a new family of antiproliferative genes. Embo J, 11, 1663-1670.
Ryo, A., Nakamura, M., Wulf, G., Liou, Y.C. and Lu, K.P. (2001) Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC. Nat Cell Biol, 3, 793-801.
Ryu, M.S., Lee, M.S., Hong, J.W., Hahn, T.R., Moon, E. and Lim, I.K. (2004) TIS21/BTG2/PC3 is expressed through PKC-delta pathway and inhibits binding of cyclin B1-Cdc2 and its activity, independent of p53 expression. Exp Cell Res, 299, 159-170.
Seo, M.S., Lee, M.S. and Lim, I.K. (1999) Expression of rat BTG(3) gene, Rbtg3, is regulated by redox changes. Gene, 240, 165-173.
Seth, A., Alvarez, E., Gupta, S. and Davis, R.J. (1991) A phosphorylation site located in the NH2-terminal domain of c-Myc increases transactivation of gene expression. J Biol Chem, 266, 23521-23524.
Sgambato, A., Ardito, R., Faraglia, B., Boninsegna, A., Wolf, F.I. and Cittadini, A. (2001) Resveratrol, a natural phenolic compound, inhibits cell proliferation and prevents oxidative DNA damage. Mutat Res, 496, 171-180.
She, Q.B., Bode, A.M., Ma, W.Y., Chen, N.Y. and Dong, Z. (2001) Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Res, 61, 1604-1610.
Shih, A., Davis, F.B., Lin, H.Y. and Davis, P.J. (2002) Resveratrol induces apoptosis in thyroid cancer cell lines via a MAPK- and p53-dependent mechanism. J Clin Endocrinol Metab, 87, 1223-1232.
Shih, A., Zhang, S., Cao, H.J., Boswell, S., Wu, Y.H., Tang, H.Y., Lennartz, M.R., Davis, F.B., Davis, P.J. and Lin, H.Y. (2004) Inhibitory effect of epidermal growth factor on resveratrol-induced apoptosis in prostate cancer cells is mediated by protein kinase C-alpha. Mol Cancer Ther, 3, 1355-1364.
Shirakawa, F. and Mizel, S.B. (1989) In vitro activation and nuclear translocation of NF-kappa B catalyzed by cyclic AMP-dependent protein kinase and protein kinase C. Mol Cell Biol, 9, 2424-2430.
Slamon, D.J., Godolphin, W., Jones, L.A., Holt, J.A., Wong, S.G., Keith, D.E., Levin, W.J., Stuart, S.G., Udove, J., Ullrich, A. and et al. (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science, 244, 707-712.
Stone, K.R., Mickey, D.D., Wunderli, H., Mickey, G.H. and Paulson, D.F. (1978) Isolation of a human prostate carcinoma cell line (DU 145). Int J Cancer, 21, 274-281.
Struckmann, K., Schraml, P., Simon, R., Elmenhorst, K., Mirlacher, M., Kononen, J. and Moch, H. (2004) Impaired expression of the cell cycle regulator BTG2 is common in clear cell renal cell carcinoma. Cancer Res, 64, 1632-1638.
Suh, J., Payvandi, F., Edelstein, L.C., Amenta, P.S., Zong, W.X., Gelinas, C. and Rabson, A.B. (2002) Mechanisms of constitutive NF-kappaB activation in human prostate cancer cells. Prostate, 52, 183-200.
Suk, K., Sipes, D.G. and Erickson, K.L. (1997) Enhancement of B-cell translocation gene-1 expression by prostaglandin E2 in macrophages and the relationship to proliferation. Immunology, 91, 121-129.
Sun, C., Hu, Y., Liu, X., Wu, T., Wang, Y., He, W. and Wei, W. (2006) Resveratrol downregulates the constitutional activation of nuclear factor-kappaB in multiple myeloma cells, leading to suppression of proliferation and invasion, arrest of cell cycle, and induction of apoptosis. Cancer Genet Cytogenet, 165, 9-19.
Suzuki, T., J, K.T., Ajima, R., Nakamura, T., Yoshida, Y. and Yamamoto, T. (2002) Phosphorylation of three regulatory serines of Tob by Erk1 and Erk2 is required for Ras-mediated cell proliferation and transformation. Genes Dev, 16, 1356-1370.
Tirone, F. (2001) The gene PC3(TIS21/BTG2), prototype member of the PC3/BTG/TOB family: regulator in control of cell growth, differentiation, and DNA repair? J Cell Physiol, 187, 155-165.
Tsui, K.H., Chang, P.L., Lin, H.T. and Juang, H.H. (2004) Down-regulation of the prostate specific antigen promoter by p53 in human prostate cancer cells. J Urol, 172, 2035-2039.
Tzachanis, D., Freeman, G.J., Hirano, N., van Puijenbroek, A.A., Delfs, M.W., Berezovskaya, A., Nadler, L.M. and Boussiotis, V.A. (2001) Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells. Nat Immunol, 2, 1174-1182.
Varnum, B.C., Reddy, S.T., Koski, R.A. and Herschman, H.R. (1994) Synthesis, degradation, and subcellular localization of proteins encoded by the primary response genes TIS7/PC4 and TIS21/PC3. J Cell Physiol, 158, 205-213.
Vogelstein, B., Lane, D. and Levine, A.J. (2000) Surfing the p53 network. Nature, 408, 307-310.
Wang, Y., Schwedes, J.F., Parks, D., Mann, K. and Tegtmeyer, P. (1995) Interaction of p53 with its consensus DNA-binding site. Mol Cell Biol, 15, 2157-2165.
Yoshida, Y., Matsuda, S., Ikematsu, N., Kawamura-Tsuzuku, J., Inazawa, J., Umemori, H. and Yamamoto, T. (1998) ANA, a novel member of Tob/BTG1 family, is expressed in the ventricular zone of the developing central nervous system. Oncogene, 16, 2687-2693.
Yoshida, Y., Matsuda, S. and Yamamoto, T. (1997) Cloning and characterization of the mouse tob gene. Gene, 191, 109-113.
Yoshida, Y., Nakamura, T., Komoda, M., Satoh, H., Suzuki, T., Tsuzuku, J.K., Miyasaka, T., Yoshida, E.H., Umemori, H., Kunisaki, R.K., Tani, K., Ishii, S., Mori, S., Suganuma, M., Noda, T. and Yamamoto, T. (2003) Mice lacking a transcriptional corepressor Tob are predisposed to cancer. Genes Dev, 17, 1201-1206.
Yoshida, Y., Tanaka, S., Umemori, H., Minowa, O., Usui, M., Ikematsu, N., Hosoda, E., Imamura, T., Kuno, J., Yamashita, T., Miyazono, K., Noda, M., Noda, T. and Yamamoto, T. (2000) Negative regulation of BMP/Smad signaling by Tob in osteoblasts. Cell, 103, 1085-1097.
Zhang, X.K. (2002) Vitamin A and apoptosis in prostate cancer. Endocr Relat Cancer, 9, 87-102.
Zong, W.X., Edelstein, L.C., Chen, C., Bash, J. and Gelinas, C. (1999) The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis. Genes Dev, 13, 382-387.
|